CAS No.: 894783-71-2
BIBF 1202 Catalog No. CSN17360
BIBF 1202 is the carboxylate metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01329549 Ovarian Neoplasms Phase 1 Terminated - Japan ... more >> 1199.117.003 Boehringer Ingelheim Investigational Site Akashi, Hyogo, Japan 1199.117.002 Boehringer Ingelheim Investigational Site Chuo-ku,Tokyo, Japan 1199.117.001 Boehringer Ingelheim Investigational Site Hidaka, Saitama, Japan Collapse << NCT01329549 - - Terminated - - NCT00806819 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - - - 更多
- 参考文献
- [1] Stopfer P, Rathgen K, et al. Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers. Xenobiotica. 2011 Apr;41(4):297-311.
- [2] Hilberg F, Roth GJ, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 2008 Jun 15;68(12):4774-82.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 894783-71-2 | 储存条件 |
|
|
| 分子式 | C30H31N5O4 | 运输 | 蓝冰 | |
| 分子量 | 525.60 | 别名 |
